AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2022 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2022 Earnings Call Transcript November 8, 2022

AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $0.05.

Operator: Good afternoon. And welcome to AbCellera’s Third Quarter 2022 Business Update Conference Call. My name is Dania, and I’ll facilitate the audio portion of today’s interactive broadcast. At this time, I’d like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance...